Cargando…

Increased tropospheric ozone levels as a public health issue during COVID-19 lockdown and estimation the related pulmonary diseases

The aims of this study were to i) investigate the variation of tropospheric ozone (O(3)) levels during the COVID-19 lockdown; ii) determine the relationships between O(3) concentrations with the number of COVID-19 cases; and iii) estimate the O(3)-related health effects in Southwestern Iran (Khorram...

Descripción completa

Detalles Bibliográficos
Autores principales: Anbari, Khatereh, Khaniabadi, Yusef Omidi, Sicard, Pierre, Naqvi, Hasan Raja, Rashidi, Rajab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish National Committee for Air Pollution Research and Control. Production and hosting by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676228/
https://www.ncbi.nlm.nih.gov/pubmed/36439075
http://dx.doi.org/10.1016/j.apr.2022.101600
Descripción
Sumario:The aims of this study were to i) investigate the variation of tropospheric ozone (O(3)) levels during the COVID-19 lockdown; ii) determine the relationships between O(3) concentrations with the number of COVID-19 cases; and iii) estimate the O(3)-related health effects in Southwestern Iran (Khorramabad) over the time period 2019–2021. The hourly O(3) data were collected from ground monitoring stations, as well as retrieved from Sentinel-5 satellite data for showing the changes in O(3) levels pre, during, and after lockdown period. The concentration-response function model was applied using relative risk (RR) values and baseline incidence (BI) to assess the O(3)-related health effects. Compared to 2019, the annual O(3) mean concentrations increased by 12.2% in 2020 and declined by 3.9% in 2021. The spatiotemporal changes showed a significant O(3) increase during COVID-19 lockdown, and a negative correlation between O(3) levels and the number of COVID-19 cases was found (r = − 0.59, p < 0.05). In 2020, the number of hospital admissions for cardiovascular diseases increased by 4.0 per 10(5) cases, the mortality for respiratory diseases increased by 0.7 per 10(5) cases, and the long-term mortality for respiratory diseases increased by 0.9 per 10(5) cases. Policy decisions are now required to reduce the surface O(3) concentrations and O(3)-related health effects in Iran.